Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07765797

Development and Validation of a Scale of Propensity for Change in Chronic Disease Prevention

Sponsor: University Hospital, Toulouse

View on ClinicalTrials.gov

Summary

Modifiable risk factors are estimated to account for 70% of cardiovascular diseases, 40% of Alzheimer's-type dementias, and 50% of type 2 diabetes cases. Numerous trials have evaluated interventions aimed at modifying these risk factors, whether through the promotion of healthy lifestyle choices (diet, physical activity, etc.) or specific activities (cognitive training, etc.). However, these trials have yielded inconsistent or modest results, potentially due to a failure to adopt the recommended lifestyle changes. To better tailor prevention interventions, it is therefore essential to have scales available that measure the barriers to and facilitators of lifestyle change. The aim of this study is to develop and validate a Patient-Reported Outcome Measure (PROM) to assess the barriers to and facilitators of change following participation in a prevention program. The scale will be structured into three sub-scales (capability, opportunity, and motivation), administered one month after the prevention activity, and will distinguish between the adoption of new habits and the abandonment of existing ones.

Official title: Development and Validation of a Propensity-to-change Scale in the Field of Chronic Disease Prevention: the ProChange Scale

Key Details

Gender

All

Age Range

45 Years - Any

Study Type

OBSERVATIONAL

Enrollment

290

Start Date

2026-09-01

Completion Date

2028-06-01

Last Updated

2026-08-14

Healthy Volunteers

Yes

Interventions

OTHER

Scale development phase

Questionnaire administered to patients to develop the scale's items and group them into subscales.

OTHER

Beta testing phase

The scale will be administered to the patient in the form of a questionnaire for the testing phase.

OTHER

Validation phase

The scale will be administered to patients in the form of questionnaires for the validation phase.

Locations (1)

Service d'Epidémiologie Clinique et de Santé Publique CHU de Toulouse, Pôle Santé Publique et Médecine Sociale Faculté de Médecine, 37 allées Jules Guesde

Toulouse, Oui, France